InsiderTrades.com logo
Crypto Crash Ahead? (27 Experts Weigh In)
From Crypto 101 Media   |   Ad
Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!
Click here to reserve your spot at the emergency crypto summit now.
James E. Rothman net worth and biography
  • Phone
  • Email
  • Website

James Rothman Biography and Net Worth

Director of Berkeley Lights
James E. Rothman founded ARIAD Pharmaceuticals, Inc. Dr. Rothman is Senior Advisor at Arsenal Capital Management LP. He is also on the board of TractManager, Inc., Berkeley Lights, Inc. and WCG Clinical, Inc. and Professor & Director-Nanobiology Institute at Yale School of Medicine.

James E. Rothman previously was Advisor at Johnson & Johnson, Consultant at Eli Lilly & Co., Consultant at GlaxoSmithKline (New Jersey), Strategic Advisor at The Courtagen Group LLC, Chief Scientist at General Electric Healthcare Technologies, Inc., Consultant at Genentech, Inc., Advisor at Amersham Plc, Professor & Director-Sulzberger Genome at The Trustees of Columbia University in The City of New York, Professor at Stanford University, Professor at Princeton University and Vice Chairman & Chairman-Cellular Biochemistry at Memorial Sloan-Kettering Cancer Center.

Dr. Rothman received a doctorate from Harvard University and an undergraduate degree from Yale University.

What is James E. Rothman's net worth?

The estimated net worth of James E. Rothman is at least $0.00 as of March 5th, 2021. Dr. Rothman owns 138,845 shares of Berkeley Lights stock worth more than $0 as of November 2nd. This net worth evaluation does not reflect any other assets that Dr. Rothman may own. Learn More about James E. Rothman's net worth.

How do I contact James E. Rothman?

The corporate mailing address for Dr. Rothman and other Berkeley Lights executives is 5858 HORTON STREET SUITE 320, EMERYVILLE CA, 94608. Berkeley Lights can also be reached via phone at 510-858-2855 and via email at [email protected]. Learn More on James E. Rothman's contact information.

Has James E. Rothman been buying or selling shares of Berkeley Lights?

James E. Rothman has not been actively trading shares of Berkeley Lights in the last ninety days. Most recently, on Monday, November 8th, James Rothman bought 4,000 shares of Berkeley Lights stock. The stock was acquired at an average cost of $24.35 per share, with a total value of $97,400.00. Learn More on James E. Rothman's trading history.

Who are Berkeley Lights' active insiders?

Berkeley Lights' insider roster includes Keith Breinlinger (Insider), Eric Hobbs (CEO), Shaun Holt (CFO), Igor Khandros (Director), Gregory Lucier (Director), Michael Marks (Director), Stuart Merkadeau (General Counsel), Scott Olrich (COO), Matthew Rosinack (CAO), and James Rothman (Director). Learn More on Berkeley Lights' active insiders.

James E. Rothman Insider Trading History at Berkeley Lights

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/8/2021Buy4,000$24.35$97,400.00View SEC Filing Icon  
3/5/2021Sell140,000$52.75$7,385,000.00138,845View SEC Filing Icon  
3/3/2021Sell72,000$60.20$4,334,400.00125,000View SEC Filing Icon  
See Full Table

James E. Rothman Buying and Selling Activity at Berkeley Lights

This chart shows James Rothman's buying and selling at Berkeley Lights by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Berkeley Lights Company Overview

Berkeley Lights logo
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.77
Low: $0.40
High: $0.99

2 Week Range

Now: N/A

Volume

N/A

Average Volume

845,024 shs

Market Capitalization

$72.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36
Crypto Crash Ahead? (27 Experts Weigh In)
From Crypto 101 Media   |   Ad
Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!
Click here to reserve your spot at the emergency crypto summit now.